Yayınlanmış 1 Ocak 2017
| Sürüm v1
Dergi makalesi
Açık
Effects of Epirubicin and Cisplatin Against 4T1 Breast Cancer Cells are Enhanced by Myrtucommulone-A
Açıklama
Background: The number of cancer cases around the world has increased according to the World Health Organization (WHO) reports, nearly 14 million new cases and 8.2 million cancer associated mortalities have been reported in 2012. Chemotherapeutic resistance is a major problematic issue in the management of patients with breast tumor.
Dosyalar
bib-dd39facd-cd60-4bd5-9ac8-69f3a1380fff.txt
Dosyalar
(257 Bytes)
| Ad | Boyut | Hepisini indir |
|---|---|---|
|
md5:6056898dae2b13c0b52f6890eddc2e4b
|
257 Bytes | Ön İzleme İndir |